Samuel Raimundo Fernandes

11PUBLICATIONS
66CO-AUTHORS
Traditional, complementary and integrative medicine not elsewhere classifiedHaematologyRegenerative medicine (incl. stem cells)Predictive and prognostic markersOther European languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 04, 2026
Transmural improvement may be an acceptable target in patients with Crohns disease.

Samuel Raimundo Fernandes, Sérgio Bronze, Inês Coelho Rodrigues

|Mar 17, 2026
Distinct hepcidin patterns in Crohn's disease and ulcerative colitis: links to iron homeostasis and inflammatory activity.

Fernando Magro, Paula Ministro, Helena Tavares de Sousa

|Jun 25, 2025
Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched Analysis.

Samuel Raimundo Fernandes, Inês Coelho Rodrigues, André Da Silva Neves

|Jan 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.

Offir Ukashi, Aurelien Amiot, David Laharie

|Jan 03, 2025
Type 2 inflammation: a Portuguese consensus using Web-Delphi and decision conferencing (INFLAT2-PT).

Suzete Costa, João Pedro Aguiar, Mónica D Oliveira

|Nov 07, 2024
Increasing evidence supporting fecal calprotectin for distinguishing Crohn's disease perianal fistulas from cryptoglandular fistulas.

Samuel Raimundo Fernandes, Inês Coelho Rodrigues

Pageof 2